MedTrace Logo

Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients

NCT03874871 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-04-08

No results posted yet for this study

Summary

The real world based multi-cohorts study aims to evaluate the safety and effectiveness of function preserving gastrectomy including pylorus-preserving distal gastrectomy, proximal gastrectomy and wedge gastrectomy for T1 and T2 gastric cancer patients.

Conditions

Interventions

PROCEDURE

Function preserving gastrectomy

Function preserving gastrectomy include pylorus preserving gastrectomy, proximal gastrectomy, and partial gastrectomy.

PROCEDURE

Standard gastrectomy

Standard gastrectomy include distal gastrectomy and total gastrectomy with standard lymphadenectomy according to the Japanese gastric cancer treatment guideline.

Sponsors & Collaborators

  • Beijing Municipal Science & Technology Commission

    collaborator OTHER

  • Peking Union Medical College Hospital

    collaborator OTHER

  • Beijing Friendship Hospital

    collaborator OTHER

  • Peking University Third Hospital

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER

  • Beijing Hospital

    collaborator OTHER_GOV

  • Peking University People's Hospital

    collaborator OTHER

  • Peking University

    lead OTHER

Principal Investigators

  • Ziyu Li, MD · Peking University Cancer Hospital & Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-20
Primary Completion
2022-03-01
Completion
2025-03-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03874871 on ClinicalTrials.gov